New data support tailoring regional nodal irradiation in patients treated with neoadjuvant chemotherapy on the basis of their ...

At a past Power Athlete event, former Navy SEAL and seasoned speaker Andy Stumpf delivered a sharp, no-nonsense lesson on goal setting that cut through the fluf ...

The Motley Fool. DATE Tuesday, June 17, 2025 at 10 a.m. ET CALL PARTICIPANTS Interim Chief Executive Officer and Board Chair ...

The risk of recurrence was generally low among cervical cancer patients with no high-risk factors who underwent radical surgery without adjuvant therapy.

ERC Advanced Grants worth a total of €721m were awarded to 281 researchers, with UCD's Prof Kylie Jarrett and Dr Barry Wardell among the winners.

Six out of ten people with type 2 diabetes had fatty liver in a new study from . Of these, only a small percentage had ...

Phase 2 trial results support Isa-KRd as a standard treatment option for patients with high-risk, newly diagnosed multiple myeloma, according to researchers.

Oesophageal adenocarcinoma has an extremely poor prognosis, and improving outcomes via therapy remains particularly challenging in such a heterogeneous cancer. Another avenue for improving outcomes ...

There’s reason to remain bullish about Merck’s growth prospects in the long run. And at a discounted price, the stock could ...

Despite calls from some corners to switch from canola oil and corn oil to beef tallow, the move is unlikely to make Americans healthier.

Long-term results from the Women’s Health Initiative have revealed associations between cancers and hormone therapy, ...

How AI, regulatory reform, and cultural diversity could help European startups challenge Silicon Valley's dominance.